Met Life Investment Management, LLC Avidity Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 62,364 shares of RNA stock, worth $2.05 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
62,364
Previous 58,347
6.88%
Holding current value
$2.05 Million
Previous $2.38 Million
20.18%
% of portfolio
0.02%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding RNA
# of Institutions
250Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$350 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$284 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$268 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$232 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.72B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...